Bicycle Therapeutics PLC (NASDAQ:BCYC)

Delayed Data
As of Dec 02
 +2.86 / +9.90%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Bicycle Therapeutics PLC have a median target of 53.50, with a high estimate of 74.00 and a low estimate of 33.00. The median estimate represents a +68.50% increase from the last price of 31.75.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Buy stock in Bicycle Therapeutics PLC. This rating has held steady since December, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Mar 14

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -11.78%
Growthannually -44.37%


Growthquarterly 13.36%
Growthannually 26.40%
Key to the earnings and sales forecast charts.